World’s First Gene Therapy Developer Hopes to Raise $128M for Hemophilia and Huntington’s – labiotech (press release) (blog)
labiotech (press release) (blog) |
World's First Gene Therapy Developer Hopes to Raise $128M for Hemophilia and Huntington's
labiotech (press release) (blog) uniQure hopes to raise a substantial public offering on the NASDAQ early next week. If successful, this could help the Dutch gene therapy pioneer recover after hitting a rough patch last year. Amsterdam-based uniQure plans to raise an ambitious $128M … |
